Although still unclear, the current evidence suggests that some inflammatory cardiomyopathies (e.g., iatrogenic cardiomyopathy) may benefit from MIF signaling, which coincides with the reported function of MIF in studies investigating myocardial infarction and remodeling. This evidence concerns the gene MIF and myocardial infarction.